Pricing

Theseus Pharmaceuticals Inc (THRX)

followers ·
Sector: HEALTH CARE
Industry: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Timothy P. Clackson
Employees: 30
Web site: theseusrx.com
314 MAIN STREET, SUITE 04-200, CAMBRIDGE, MA, 02142
(857) 400-9491

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

All 13F Filers Prior Change Hedge Funds 1 Prior Change
Theseus Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of targeted therapies for cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors, which is in Phase I clinical trial. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available